Short-term effects of nicotine on bone and calciotropic hormones in adult female rats

Pharmacology and Toxicology

Volumn 82, Issue 5, 1998, Pages 243-249

  Fung, Yiu K ^a   Mendlik, Mark G ^a   Haven, Mary C ^b   Akhter, Mohammed P ^c   Kimmel, Donald B ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITONIN; CALCITRIOL; NICOTINE; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE STRENGTH; CONTROLLED STUDY; FEMALE; FEMUR; HORMONE BLOOD LEVEL; LUMBAR VERTEBRA; NONHUMAN; PRIORITY JOURNAL; RAT; TIBIA;

ANIMALIA;

EID: 0031812810     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01432.x     Document Type: Article

References (54)

1. Avioli, L. V.: Calcium and osteoporosis. Ann. Rev. Nutr. 1984, 4, 471-491.
2. Balfour, D. J. K. & K. O. Fagerstrom: Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol. Therap. 1996, 72, 51-81.
3. Baron, J. A., R. J. Comi, V. Cryns, T. Brinck-Johsen & N. G. Mercer: The effect of cigarette smoking on adrenal cortical hormones. J. Pharmacol. Exp. Therap. 1995, 272, 151-155.
4. Baron, R., A. Vignery, L. Neff, A. Silverglate & A. Santa Maria: Processing of undecalcified hone specimens for bone histomorphometry. In: Bone histomorphometry: Techniques and interpretation. Ed.: R. R. Recker. CRC, Boca Raton, Florida, 1983, 13-35.
5. Benowitz, N. L., P. Jacob & L. Yu: Daily use of smokeless tobacco: Systemic effects. Ann. Int. Med. 1989, 111, 112-126.
6. Benowitz, N. L.: Pharmacologic aspects of cigarette smoking and nicotine addiction: New Engl. J. Med. 1988, 319, 1318-1330.
7. Bikle, D. D.: Role of vitamin D, its metabolites and analogs in the management of osteoporosis. Rheum. Dis. Clin. North Am., 20, 759-775, 1994.
8. Broulik, P.D. & J. Jarab: The effect of chronic nicotine administration on bone mineral content in mice: Hormone Metab. Res. 1993, 25, 219-221.
9. Civitelli, R. & L. V Avioli: The biochemistry and function of calciotropic hormones. In: Calcium-regulating hormones and cardiovascular function. Eds.: M. F. Crass, III. & L. V. Avioli. CRC Press Inc. Fl. 1995, 1-44.
10. Daniell, H. W.: Osteoporosis of the slender smoker. Arch. Int. Med. 1976, 136, 298-304.
11. DeLuca, H. F.: New concepts of vitamin D functions. Ann. N. Y. Acad. Sci. 1992, 669, 59-68.
12. Eskandar, E., D. B. Kimmel & T. J. Wronski: Rapid determination of cancellous bone mineral loss in ovariectomized rats by a subtraction technique. Anat Rec. 1991, 230, 169-174.
13. Fang, M. A., P. J. Frost, K. A. Lida & T. J. Hahn: Effects of nicotine on cellular function in UMR 106-01 osteoblast-like cells: Bone 1991, 12, 283-286.
14. Frost, H. M.: Bone histomorphometry: analysis of trabecular bone dynamics. In: Bone histomorphometry: Techniques and interpretation. Ed.: R. R. Recker. CRC Press, Boca Raton, Florida, 1983, 109-142.
15. Frost, H. M. & W. S. S. Jee: On the rat model of human osteopenias and osteoporoses. Bone and Mineral 1992, 18, 227-236.
16. Fung, Y. K., M. J. Schmid, T. M. Anderson & Y.-S. Lau: Effects of nicotine withdrawal on central dopaminergic system. Pharmacol. Biochem. Behav. 1996, 53, 635-640.
17. Fuxe, K., K. Andersson, P. Eneroth, A. Harstrand & L. F. Agnati: Neuroendocrine actions of nicotine and of exposure to cigarette smoke: medical complications. Psychoneuroendocrinol. 1989, 14, 14-41.
18. 3 on calcium balance and bone turnover and its effect on vertebral fracture rate. Metabol. 1990, 39, 30-34.
19. Goldner, J.: A modification of the Masson trichrome technique for routine laboratory purposes. Amer. J. Pathol. 1938, 14, 237-243.
20. Grunberg, N. E., D. J. Bowen & D. E. Morse: Effects of nicotine on body weight and food consumption in rats. Psychopharmacol. 1984, 83, 93-98.
21. Holmes, H., M. J. Jarvis, M. A. H. Russell & C. Feyerabend: Nicotine intake and dependence in Swedish snuff takers. Psychopharmacol. 1992, 108, 507-511.
22. Hollis, B. W.: Assay of circulating 1,25-dihydroxyvitamin D involving a novel single cartridge extraction and purification procedure. Clin. Chem. 1986, 32, 2060-2063.
23. Hui, S. L., C. W. Slemenda & C. C. Johnson: The contribution of bone loss to postmenopausal osteoporosis. Osteo. Int. 1990, 1, 30-34.
24. Jacob, III, J., M. Wilson & N. L. Benowitz: Improved gas Chromatographic method for the determination of nicotine and cotinine in biological fluids. J Chrom. Biomed. Appl. 1981, 222, 61-70.
25. 2 in humans. Biol. Mass. Spect. 1991, 20, 247-252.
26. Jensen, C. F:. Osteoporosis of the slender smoker revisited by epidemiologic approach. Eur. J. Clin. Invest. 1986, 16, 239-243.
27. Jensen, J. & C. Christiansen: Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Amer. J. Obstet. Gynecol. 1988, 159, 820-825.
28. Kimmel, D. B. & T. J. Wronski: Non-destructive measurement of bone mineral in femurs from ovariectomized rats. Calc. Tiss. Int. 1990, 46, 101-110.
29. Kimmel, D. B., R. P. Bozzato, K. A. Kronis, T. Coble, D. Sindrey, P. Kwong & R. R. Recker: The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteogenic ovariectomized rats. Endocrinol. 1993, 132, 1577-1584.
30. Kinyamu, H. K., J. C. Gallagher, K. M. Petranick & K. L. Ryschon: Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25 dihydroxyvitamin D and parathyroid hormone in normal women. J. Bone Min. Res. 1996, 11, 1400-1405.
31. Lane, N., T. Coble & D. B. Kimmel: Effect of naproxen on cancellous bone in ovariectomized rats. J. Bone Min. Res. 1990, 5, 1029-1035.
32. Laroche, M., Y. Lasne, A. Felez, L. Moulinier, E. Bon, A. Cantagrel, P. Leophonte & B. Maziere: Osteocalcin and smoking. Rev. Rhum. Ed. Fr. 1994, 61, 433-136.
33. Law, M.: Smoking and osteoporosis. In: Smoking and hormone-related disorders. Eds.: N. Wald & J. Baron. Oxford University Press, N.Y. 1990, 83-92.
34. Lindsay, R.: The influence of cigarette smoking on bone mass and bone loss. In: Osteoporosis: Recent advances in pathogenesis and treatment. Eds.: H. F. DeLuca, H. M. Frost, W. S. S. Jee, C. C. Johston & A. M. Parfitt. UPP, Baltimore, 1981, 481.
35. Marcus, S. E., G. A. Giovino, J. P. Pierce & Y. Harel: Measuring tobacco use among adolescents. Pub. Health Reports, 1993, 108, 20-24.
36. Moon, J., B. Bandy & A. J. Davison: Hypothesis: Etiology of atherosclerosis and osteoporosis: Are imbalance in the calciferol endocrine system implicated? J. Amer. Coll. Nutr., 1992, 11, 567-583.
37. Morse, D. E.: Neuroendocrine responses to nicotine and stress: enhancement of peripheral stress responses by the administration of nicotine. Psychopharmacol. 1989, 98, 539-543.
38. Mosekilde, L., C. C. Danielsen & U. N. Knudsen: The effect of aging and ovariectomy on the vertebral bone mass and biomechanical properties of mature rats. Bone 1993, 14, 1-6.
39. Murrin, L. C., J. R. Ferrer, W. Zeng & N. J. Haley: Nicotine administration to rats: Methodological consideration. Life Sci. 1987, 40, 1699-1708.
40. Nash, J. E. & T. V. N. Persaud: Influence of nicotine and caffeine on skeletal development in the rat. Anat. Anz. Jena 1989, 168, 109-126.
41. Parfitt, A. M., M. K. Drezner, F. H. Glorieux, J. A. Kanis, H. Malluche, P. J. Meunier, S. M. Ott & R. R. Recker: Bone histomorphometry: standardization of nomenclature, symbols, and units. J. Bone Min. Res. 1987, 2, 595-609.
42. Parfitt, A. M., C.H.E. Mathews, A. R. Villanueva, M. Kleerekoper, B. Frame & D. S. Rao:Relationships between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. J. Clin. Inv. 1983, 72, 1396-1409.
43. Ramp, W. K., L. G. Lenz & R. J. Galvin: Nicotine inhibits collagen synthesis and alkaline phosphatase activity, but stimulates DNA synthesis in osteoblast-like cells. Proc. Soc. Exp. Biol. Med. 1991, 197, 36-43.
44. Reichel, H., P. Koeffler & A. W. Norman: The role of the vitamin D endocrine system in health and disease. New. Engl. J. Med. 1989, 320, 980-991.
45. Riggs, B. L., H. W. Wahner, W. L., Dunn, R. B. Mazess, K. P. Offord & L. J. Melton: Differential changes in bone mineral density of the appendicular and axial skeleton with aging. J. Clin. Invest. 1981, 67, 328-335.
46. Robertson, P. B., T. A. Derouen, V. Ernster, D. Grady, J. Greene, L. Mancl, D. McDonald & M. M. Walsh: Smokeless tobacco use: How it affects the performance of major league baseball players. JADA 1995, 126, 1115-1124.
47. Rodu, B.: An alternative approach to smoking control. Amer. J. Med. Sci. 1994, 308, 32-34.
48. Stolerman, I. P., N. R. Mirza & M. Shoaib: Nicotine psychopharmacology: Addiction, cognition and neuroadaptation. Med. Res. Rev. 1995, 15, 47-72.
49. Szũcs, J.: Osteoporosis from the point of view of the clinical endocrinologist. Agents Actions 1994, 41, 80-83.
50. Tang, L. Y., W. S. S. Jee, H. Z. Ke & D. B. Kimmel: Restoring and maintaining bone in osteogenic female rat skeleton: 1. Changes in bone mass and structure. J. Bone Min. Res. 1992, 7, 1093-1104.
51. U.S. Department of Health and Human Services: Preventing tobacco use among young people: A report of the surgeon general. Atlanta, Georgia. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Washington D.C. 1994, 15-52.
52. Villanueva, A. R. & K. D. Lundin: A versatile new mineralized bone stain for simultaneous assessment of tetracycline and osteoid seams. Stain Techn. 1989, 64, 129-138.
53. Walters, M. R.: Newly identified actions of vitamin D endocrine system. Endocr. Rev. 1992, 13, 719-764.
54. Wilkins, J. N., H. E. Carlson, H. V. Vunakis, M. A. Hill, E. Gritz & M. E. Jarvik: Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers: Psychopharmacol 1982, 78, 305-308.